Aesica is a leading supplier of the active ingredient flurbiprofen and the modified S+flurbiprofen, and has supplied the product into the Japanese market for many years. Demand for the new formulation is expected to grow steadily from 2016.

To find out more information,contact enquiries@aesica-pharma.com

THE WHOLE SUPPLY CHAIN. SIMPLIFIED.

How Aesica can add value at every stage

Finished dose development – Finished dose manufacture – API development